Home › Funds › SCHARF INVESTMENTS, LLC › CVS
SCHARF INVESTMENTS, LLC position in CVS
CVS HEALTH CORP · Consumer Staples
SCHARF INVESTMENTS, LLC reported holding 93,264 shares of CVS (CVS HEALTH CORP) in its Q3 2026 13F filing — a position valued at US$8.0M, representing 0.27% of its reported portfolio and ranking #35 among its reported holdings. SCHARF INVESTMENTS, LLC has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SCHARF INVESTMENTS, LLC's CVS position evolved
SCHARF INVESTMENTS, LLC first disclosed a stake in CVS in Q3 2023 at 2,211,506 shares (US$154.4M). The position peaked in Q4 2023 at 2,189,552 shares, worth US$172.9M. Across 13 filings, SCHARF INVESTMENTS, LLC increased the stake 1 time(s), trimmed it 11 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 93,264 shares valued at US$8.0M — a reduction of -603 shares quarter over quarter.. Notable position changes include a 46% trim in Q4 2024 (shares rose 53% over the following quarter), a 84% trim in Q1 2025 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.21M | $154.41M | New |
| Q4 2023 | 2.19M | $172.89M | Reduce |
| Q1 2024 | 2.11M | $168.66M | Reduce |
| Q2 2024 | 1.98M | $117.15M | Reduce |
| Q3 2024 | 1.91M | $119.80M | Reduce |
| Q4 2024 | 1.02M | $59.64M | Reduce |
| Q1 2025 | 159.81K | $10.83M | Reduce |
| Q2 2025 | 125.89K | $8.68M | Reduce |
| Q3 2025 | 101.39K | $7.64M | Reduce |
| Q4 2025 | 103.50K | $8.21M | Add |
| Q1 2026 | 96.17K | $6.91M | Reduce |
| Q2 2026 | 93.87K | $9.71M | Reduce |
| Q3 2026 | 93.26K | $7.99M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CVS and 13F data
CVS (CVS HEALTH CORP) is a Consumer Staples company. 31 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$6.35B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CVS
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Capital World Investors 74.04M sh · $6.35B · Q3 2026
- Dodge & Cox 50.01M sh · $5.17B · Q2 2026
- DODGE & COX 50.01M sh · $5.17B · Q2 2026
- Wellington Management Group 33.80M sh · $3.50B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 33.80M sh · $3.50B · Q2 2026
- DAVIS SELECTED ADVISERS 11.90M sh · $1.02B · Q3 2026
- Pzena Investment Management 10.30M sh · $882.34M · Q3 2026
More on SCHARF INVESTMENTS, LLC
FAQ
How long has SCHARF INVESTMENTS, LLC held CVS?
SCHARF INVESTMENTS, LLC has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is SCHARF INVESTMENTS, LLC's current position in CVS?
As of Q3 2026, SCHARF INVESTMENTS, LLC holds 93.26K shares of CVS (CVS HEALTH CORP), valued at $7.99M, representing 0.27% of its reported portfolio and ranking #35.
Has SCHARF INVESTMENTS, LLC been buying or selling CVS?
In the latest 13F filing (Q3 2026), SCHARF INVESTMENTS, LLC reduced its position in CVS. The position peaked in Q4 2023 at 2.19M shares.
Which other funds hold CVS?
Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.